Company Overview and News

 
PSE on track to breach P200-B fund-raising target

6h bworldonline
THE PHILIPPINE STOCK Exchange, Inc. (PSE) is optimistic it can breach its P200-billion full-year target for fund-raising activities at the local bourse, as the share sale of San Miguel Corp.’s food and beverage unit pushes through in the fourth quarter.
IRC SMCP1 RZLLY SUAFF RBLAY RCB CKGOY SMGBF SMC PHSXY IMI PSE BCDTY PSKXF CHIB BSC DD SMGBY SMC2B SMC2A SMC2D RLC SMC2C SMC2F SMC2E PERC FNI

8
Capital raised via stock market hits P150 billion in first half

2018-07-01 bworldonline
CAPITAL raised at the stock market reached a record P150 billion in the first half, as companies braved the local market amid prevailing volatility.
IRC PSKXF CHIB SUAFF RBLAY BSC DD CKGOY RLC PHSXY PSE FNI BCDTY

92
Select Energy: A Misunderstood And Deeply Undervalued Energy Franchise With A Wide Moat

2018-06-06 seekingalpha
Select Energy Services, Inc. is a unique growth company with no other direct comparables. If you are invested in fracking or Permian-related stocks, this is a must-read article.
APA XOM DVN WTTR PE HCLP COP EMES JAG BCDTY FRAC SLB LBRT VNOM FTSI BSC EOG BHI PTEN GRR CVX PUMP SLB SND TTI OXY FANG

22
Mammoth Energy: Unsustainable Contract, Sum-Of-The-Parts Indicate 50% Downside

2018-04-24 seekingalpha
Sum of the parts and peer comps suggests 50%+ of value is due to its new T&D infrastructure business.
BAS TUSK UNP PRIM WGRP GPOR FLR BSC BCDTY WG HCLP

 
Basic Energy raises investment in 2 Thai firms

2018-03-27 bworldonline
BASIC ENERGY Corp. on Tuesday said its board of directors gave the go-signal to increase the company’s equity investment in two Thai companies to 15%.
BSC BCDTY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:BSC / Basic Energy Corporation on message board site Silicon Investor.

Brokerage Stocks - MWD, MER, BSC, PWJ and All The Rest Brokerage Stocks - MWD, MER, BSC, PWJ and All The Rest Brokerage Stocks - MWD, MER, BSC, PWJ and All The Rest New Brunswick Scientific Co., Inc. (NBSC) New Brunswick Scientific Co., Inc. (NBSC) New Brunswick Scientific Co., Inc. (NBSC)
Bear Stearns BSC Bear Stearns BSC Bear Stearns BSC Bear Stearns Cou0027s (NYSE:BSC) Bear Stearns Cou0027s (NYSE:BSC) Bear Stearns Cou0027s (NYSE:BSC)
TIW EXCEEDS FIVE MILLION SUBSCRIBERS IN CENTRAL AND EASTERN TIW EXCEEDS FIVE MILLION SUBSCRIBERS IN CENTRAL AND EASTERN TIW EXCEEDS FIVE MILLION SUBSCRIBERS IN CENTRAL AND EASTERN An obscure ZIM in Africa traded Down Under An obscure ZIM in Africa traded Down Under An obscure ZIM in Africa traded Down Under
Aurora Biosciences (ABSC) Aurora Biosciences (ABSC) Aurora Biosciences (ABSC) PBSC - Packard BioScience PBSC - Packard BioScience PBSC - Packard BioScience
IQ Chart - Live Discussions with Subscribers and Staff IQ Chart - Live Discussions with Subscribers and Staff IQ Chart - Live Discussions with Subscribers and Staff ABSC: Aurora Biosciences Corp. ABSC: Aurora Biosciences Corp. ABSC: Aurora Biosciences Corp.